Treatment and prognosis of 70 nasal non-Hodgkin lymphoma patients
10.3760/cma.j.issn.1009-9921.2008.04.018
- VernacularTitle:鼻腔非霍奇金淋巴瘤70例
- Author:
Zhaoyuan LI
;
Shanshan FANG
;
Haisheng XU
;
Xianqi GONG
;
Tienan YI
- Publication Type:Journal Article
- Keywords:
Lymphoma,non-Hodgkin;
Radiotherapy;
Drug therapy;
Prognosis;
Nasal cavity
- From:
Journal of Leukemia & Lymphoma
2008;17(4):291-292
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the initial response rate of radiotherapy and chemotherapy,and the influence of different treatment modalities on pmgnnsis of primary non-Hodgkin lymphoma(NHL)of the nascl cavity.Methods From January 1993 to December 2002,70 patients were confirmed by histopathology as NHL,including 52 T cell origin,2 B cell and 16 NK cell.The main radiotherapy portal was set in front of the nose with a spade like protrusion,supplement with a portal next to the ear on one side or both sides.Combined portal in facial cervical area was first used when there was invasion of the oropharynx.The median dose to the nasal cavity wag 54.0 Gy with a range of 336 to 66 Gy,given before or during after radiotherapy or alone,consisted of 2-6 cycles chemotherapy of COP,CHOP or COBDP.Prognostic factors were analyzed with Cox model. Results The local control rates was 12.5%, 66.7% and 74.0% in chemotherapy alone,radiotherapy alone,and chemotherapy plus radiotherapy.The 5-year survival rate Wag 12.5%,50.0% and 62.0%,respectively(P＜0.05).Multifaetor analysis showed that tumor extension and treatment methods were the most important prognostic factors besides Ann-Arbor stage,but gender,pathology,age and symptoms had little effect on prognosis.Conclusion Chemotherapy plus radiotherapy group achieved a better survival rate than radiotherapy alone.For some NHL patients with good financial condition,APBSCT is a good choice.
